Kornitzer Capital Management’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
AIM
NAMA
Kornitzer Capital Management's EXAS Position: Q2 2022 in Review
Kornitzer Capital Management sold out of Exact Sciences (EXAS) in Q2 2022, closing a stake of 16,470 shares — an estimated $1.15M sold.
Kornitzer Capital Management first reported a position in EXAS in Q2 2016 and held it in 23 quarters. The position peaked at $34.4M in Q2 2019. 501 funds tracked by Wall St. Rank hold EXAS as of Q2 2022.
- Kornitzer Capital Management reported no remaining Exact Sciences position as of Q2 2022 after selling out during the quarter.
- Kornitzer Capital Management sold 16,470 Exact Sciences shares in Q2 2022, an estimated $1.15M.
- Kornitzer Capital Management first reported a position in Exact Sciences in Q2 2016 and held it in 23 quarters.
- Kornitzer Capital Management's Exact Sciences position peaked at $34.4M in Q2 2019.
- 501 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2022.
Based on Kornitzer Capital Management's 13F filing for Q2 2022, filed 3 Aug 2022.